Unlocking the Potential of Genetic Innovation
Tsingke is a leading gene factory that specializes in providing a wide range of DNA/RNA services. Our services encompass Gene Synthesis, Oligo Synthesis, Protein Expression, Antibody and more. With state-of-the-art technology and a team of experienced scientists, we deliver high-quality solutions tailored to meet the diverse needs of our clients in fields such as biotechnology, pharmaceuticals, and academic research. Explore further to find out your ideal genetic service!
Tsynth™ Gene Synthesis
Tsingke provides top-tier genes, boasting lengths of up to 200 kb tailored to diverse research requirements. Genes come with Tsingke cloning vectors or a choice of 160+ custom vectors, all without cloning fees.
Oligo Synthesis
Tsingke offers versatile oligo solutions with 200 modifications and multiple purification options. Our efficient platform, equipped with cutting-edge synthesizers and stringent quality management system.
Protein Expression
One-stop service from gene to recombinant protein expression to meet customer's needs for specific applications.
Custom RNA Oligos
Tsingke privides various synthesis types available, such as sgRNA, siRNA, miRNA, etc and high quality through Mass Spectrometry and HPLC strict quality control.
Preparing for the Next Pandemic: Evolution, Pathogenesis and Virology of Coronaviruses
December 2-5, 2024
Awaji Yumebutai Conference Center, JAPAN
Learn More
About Tsingke
Tsingke is the pioneering DNA/RNA synthesis company, delivering reliable products and services for biotechnology research, drug development, etc. With over 200 modifications and multiple purification options, our custom oligos are of the highest quality at competitive prices. Leveraging cutting-edge R&D and automated production systems, we deliver top-tier gene synthesis and oligo synthesis services. Backed by cutting-edge technology and stringent quality control, Tsingke unlocks possibilities in genetics for various fields including IVD, antibody drug discovery, and synthetic biology solutions.
You’ll Find Tsingke Cited in More than Twelve Thousand Publications
Enhancing rice panicle branching and grain yield through tissue-specific brassinosteroid inhibition
Researchers cloned the causal gene for clustered-spikelet rice (CL), uncovering a tissue-specific BR pathway that enhances grain number without compromising size. This discovery reveals a novel role of brassinosteroids (BRs) in regulating panicle branching and offers strategies for improving crop yield by manipulating BR distribution.
Enhancing rice panicle branching and grain yield through tissue-specific brassinosteroid inhibition
Molecular basis of methyl-salicylate-mediated plant airborne defence
Researchers discovered a signaling circuit involving MeSA, SABP2, NAC2, and SAMT1 that mediates airborne defense (AD) against aphids and viruses, revealing aphid–virus co-evolution.
Molecular basis of methyl-salicylate-mediated plant airborne defence
CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis
Researchers identified circPPAP2B, a circular RNA overexpressed in metastatic ccRCC, promoting proliferation and metastasis via HNRNPC-dependent splicing and miR-182-5p/CYP1B1.
CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis
A plant mechanism of hijacking pathogen virulence factors to trigger innate immunity
Researchers revealed that Phaseolus vulgaris PGIP2 binds Fusarium polygalacturonase, enhancing substrate binding and shifting enzyme activity to trigger plant immunity.
A plant mechanism of hijacking pathogen virulence factors to trigger innate immunity
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
Researchers identified CPT1A as a key regulator of ferroptosis resistance in lung cancer stem cells, suggesting targeting CPT1A to enhance immunotherapy efficacy.
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway
Researchers identified TRPM2-AS as a key regulator of angiogenesis in gallbladder cancer, promoting angiogenesis via the NOTCH1 pathway, making it a potential therapeutic target.
Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway
Conatct
Welcome to Contact Us!
We are here to help. Let's explore how we can assist you. Whether you have questions, suggestions, or collaboration opportunities, feel free to reach out. Our team is ready to provide support and discuss how we can best meet your needs.
Those with * are required
pop_close
pop_main
Subscribe to Our Newsletter
Stay updated with the latest industry news and expert insights. Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!